Open Nav

Please submit your session questions in advance at http://bit.ly/BIOCEO19question

George Chi

Chief Financial Officer

CASI Pharmaceuticals, Inc.

Mr. Chi joined CASI Pharmaceuticals in October 2018 as Chief Financial Officer. Prior to joining CASI, Mr. Chi was Vice President of Finance at Flavors Holdings where he led the global accounting function, including financial reporting, planning, treasury, investor relations, tax & auditing with global sales in 90 countries. Prior to Flavor Holdings, from 2014-2016, he was Chief Financial Officer at BPL Plasma delivering 60% sales growth and 300% EBITDA growth for a $180 million business. He consolidated business and finance operations to prepare for an IPO where the business was sold four times of the investment in three years. From 2008-2013, he was finance director at Unilever where he was responsible for leading the accounting function including financial reporting, annual budgeting & strategic planning for a $10 billion business across 12 categories. He also successfully managed a $12 billion debt portfolio & coordinate with investment banks for annual debt issuance and repayment.

This speaker's sessions:

Back